Meet Regi,
your compliance
superpower.

Turn complex medical device regulations into step-by-step, audit-ready workflows. Built for SaMD and AI device teams navigating UKCA, EU MDR, and FDA.

Try Regi free
UKCA EU MDR / IVDR FDA

Process

How Regi works

01
Select your device workspace

Start at the dashboard and select or create a dedicated workspace for your device. Each workspace is isolated, so your data stays where it belongs.

02
Build documentation with guided wizards

Use Document Wizards to input data step by step. AI Assist provides real-time hazard suggestions and input feedback, while Guidance Panels explain what each step requires and why.

03
Data flows across modules automatically

Hazards, clinical inputs, and intended use captured once flow automatically across risk, evidence, and PMS modules, keeping every part of the file consistent without manual reconciliation.

04
Traceability and monitoring, continuously maintained

The platform updates traceability links between hazards, controls, and verification as documentation evolves. Post-market monitoring runs continuously in the background.

05
Adverse events triaged, signals flagged

AI triages adverse events and the trend analysis engine monitors signals and severity escalations, so periodic reporting is grounded in live evidence rather than a manual sweep.

06
You stay in control throughout

Accept, decline, or refine AI suggestions at every stage. Nothing progresses without your review and sign-off. Outputs remain under human control from first input to final export.

Compliance progress
✓Classification complete ✓Intended use locked ✗PMS plan active ✗UKCA pathway ✗EU MDR pathway ✗FDA pathway

The platform

Don't let regulation become a barrier.

Reduce time-to-market without compromising compliance. Regi operationalises compliance at every stage of your regulatory journey, from initial concept, through launch, and beyond.

Workflow-first execution

Requirements become step-by-step workflows with plain-language guidance at each step. Capture inputs once and outputs stay consistent as the product evolves.

Comprehensive platform

Device workspaces covering pre-market, post-market, traceability, and multi-jurisdiction compliance. Document Wizards guide creation of PMS plans, clinical evaluations, and risk files.

Audit-ready outputs

Produce consistent, defensible artefacts across UKCA, EU MDR/IVDR and FDA. Every output keeps a traceable thread from intent to evidence.


See it in action

From intended purpose to regulatory clarity, in minutes

Walk through the full assessment flow — from intended purpose to classification, pathway map, and a regulator-ready report, all generated from your inputs.

01

Intended Purpose Builder

Define your device's intended purpose with structured guidance. AI Assist flags clinical context, patient population, and use-condition gaps in real time as you type. Wording shapes classification, and Regi shows you how.

Guided writing Live AI feedback Completeness check
02

Instant Classification

Your intended purpose statement is assessed across UKCA, EU MDR, and FDA simultaneously. Classification results appear instantly, with the exact rule applied and a plain-language explanation for each jurisdiction.

3 jurisdictions at once Rule citations Human review step
03

Regulatory Pathway Map

A complete market entry roadmap for each jurisdiction, derived automatically from your classification. Every requirement is listed with its current status (done, in progress, or to do), so nothing is missed.

Per-jurisdiction roadmap Progress tracked No manual research
04

Assessment Report

A structured, regulator-ready report generated from your inputs. Every classification decision is linked and traceable. Export and maintain it alongside your QMS, with no copy-paste and no manual formatting.

Regulator-ready format Full audit trail One-click export
✓
Qualify
2
Purpose
3
Classify
4
Pathway
5
Assessment
Intended Purpose Builder
Your intended purpose statement directly determines your device's classification. As you type, we'll show how your wording affects classification in real time.
Intended Purpose Statement Use a template
[Device name] is a software-only device intended to analyse imaging modality in adult patients suspected of [condition]. The software identifies [features] and presents findings for review by a qualified [clinician type] as a decision support tool.
▲ Diagnostic claim ▲ Clinical decision support ▲ Medical imaging analysis
Statement Completeness
✓ States what the device does
✓ Identifies the intended user
✓ Identifies patient population
✓ Identifies the clinical context
✓ No contradictory claims
Live Analysis
Detected Flags
Diagnostic claimSoftware that provides diagnostic…
Clinical decision supportCDSS is regulated as a medical…
Likely Classification
UK (UKCA)Class IIa
EU (MDR)Class IIa
US (FDA)Class II
✓
Qualify
✓
Purpose
3
Classify
4
Pathway
5
Assessment
Your device likely falls into Class II.
3 jurisdictions assessed · 2× Class IIa · 1× Class II
UK (UKCA)Class IIa
UK MDR 2002, Schedule 2 (Diagnostic Information)
✓ Notified body required
The device is standalone software intended to analyse imaging modality and provide information for review by a qualified clinician, aligning with Class IIa classification for diagnostic software.
View regulation textI disagree with this result
EU (MDR)Class IIa
EU MDR 2017/745, Annex VIII (Diagnostic Information)
✓ Notified body required
Software intended to provide information for diagnosis or therapeutic purposes classified as Class IIa under Annex VIII, Rule 11.
US (FDA)Class II
21 CFR + FDA SaMD Framework
✓ FDA review required
Decision support tool meeting all four criteria for moderate risk classification as a Class II device.
← Edit Intended Purpose See Your Regulatory Pathway →
✓
Qualify
✓
Purpose
✓
Classify
4
Pathway
5
Assessment
Regulatory Pathway Map
Based on your classification, here are the complete regulatory pathways for your device across 3 jurisdictions.
UK (UKCA)IIa
MHRA Registration✓ Done
CE-QS Requirements✓ Done
CE-DS RequirementsIn progress
UK RepresentativeIn progress
UDI AssignmentTo do
Technical DocsTo do
EU (MDR)IIa
CE-QS Requirements✓ Done
Device Classification✓ Done
EU Auth. Rep.In progress
EUDAMED Reg.To do
Technical FileTo do
PMS Plan & PMCFTo do
US (FDA)II
FDA Estab. Registration✓ Done
Device Listing✓ Done
510(k) PremarketIn progress
Agent DesignationTo do
QMS / 21 CFR Part 820To do
✓
Qualify
✓
Purpose
✓
Classify
✓
Pathway
5
Assessment
Regulatory Pathway Assessment
Your regulatory pathway assessment results.
UK (UKCA) Class IIa EU (MDR) Class IIa US (FDA) Class II Based on your pathway assessment
Regulatory Assessment Report Ref: CJD-20260321 · 2026-03-21
1. Device Identity Summary
Device TypeSaMD
Target JurisdictionsUK, EU, US
Intended PurposeDecision support: medical imaging analysis
2. Classification: UKCA
ClassificationClass IIa
Rule AppliedUK MDR 2002 (as amended), Schedule 2
3. Classification: EU MDR
ClassificationClass IIa
Rule AppliedEU MDR 2017/745, Annex VIII Rule 11
↓ Export Full Report
This document is a regulatory support output generated by Regi. It does not constitute legal advice or a regulatory determination. All outputs should be reviewed by a qualified regulatory professional.

Intended Purpose Builder

Define your device's intended purpose with structured guidance. AI Assist flags clinical context, patient population, and use-condition gaps in real time as you type. Wording shapes classification, and Regi shows you how.

Instant Classification

Your intended purpose statement is assessed across UKCA, EU MDR, and FDA simultaneously. Classification results appear instantly, with the exact rule applied and a plain-language explanation for each jurisdiction.

Regulatory Pathway Map

A complete market entry roadmap for each jurisdiction, derived automatically from your classification. Every requirement is listed with its current status (done, in progress, or to do), so nothing is missed.

Assessment Report

A structured, regulator-ready report generated from your inputs. Every classification decision is linked and traceable. Export and maintain it alongside your QMS, with no copy-paste and no manual formatting.


What sets Regi apart

Built for the full lifecycle

Regi isn't your QMS or RIM. It's the execution layer that turns fragmented regulatory expectations into step-by-step, auditable workflows, so teams produce review-ready outputs and run consistent pre-market and post-market operations as the product evolves.

Workflow execution, not just documents

Capture inputs once, then keep outputs consistent and up to date as the product changes. No duplicated effort, no stale docs.

Built for the full lifecycle

Use Regi for early framing and submission readiness, then stay on top of post-market work without starting over.

Evidence quality at source

Regi shows what evidence is needed, why it matters, and how assessors are likely to evaluate it. AI-generated search protocols for literature reviews give you a structured starting point, with human-in-the-loop editing before anything is finalised.

Explainable and audit-ready by design

Every output keeps a traceable thread from intended purpose, risks and controls, to evidence and PMS. Reviews are quicker; documentation is easier to defend.

AI with guardrails: accountability stays with you

Regi's AI Assist suggests potential hazards, gives contextual feedback on your inputs, and grounds recommendations in applicable guidelines, legislation, and your internal data. It flags gaps, contradictions, and drift. You review, approve, and sign off.

Cross-framework, one evidence problem

Treat UKCA, EU MDR/IVDR and FDA as one evidence problem with tailored outputs for each. Reuse core work when expanding markets or releasing new versions.

Post-market surveillance built to catch signals

AI-powered adverse event triage and a trend analysis engine monitor signal strength and severity across your post-market data, so periodic reporting is grounded in live evidence rather than a manual sweep.

Full traceability from hazard to evidence

The Traceability Hub and built-in Essential Requirements Matrix (GSPR) link every identified hazard to its risk controls and verification evidence, giving reviewers and auditors a complete, defensible thread from intended purpose to proof.


Who uses Regi

Built for teams at every stage

Startups & early stage

Submission readiness without a regulatory department

Regi provides a structured support system to help you approach regulated markets with confidence. Auditable, defensible intelligence prevents common mistakes.

Learn more →

Multi-product teams

Operational consistency across products and markets

Regi creates repeatable regulatory execution with built-in rationale capture and traceability, improving consistency and audit posture across a portfolio.

Learn more →

Consulting & advisory

Scale delivery without scaling headcount

Deliver consistent, audit-ready client artefacts faster, with embedded explainability and clean handover, without losing editorial control.

Learn more →

FAQs

Common questions

Still not sure? Get in touch and we'll walk you through the platform.

Talk to us
Regi is a workflow-based regulatory execution platform for teams building Software as a Medical Device (SaMD) and AI-enabled medical devices. It turns complex regulatory expectations into step-by-step, review-ready workflows across the product lifecycle.
Regi is designed to produce regulator-ready outputs aligned to UKCA, EU MDR, and FDA expectations, helping teams structure evidence and documentation for those pathways.
Regi breaks regulatory tasks into structured flows that prompt for required inputs, explain why each input matters, and map everything into coherent outputs. This reduces late-stage surprises by checking completeness and consistency as you work.
Regi supports execution across pre-market and post-market, starting with early regulatory framing, through preparation and maintenance of core regulatory documentation, and into structured post-market handling and periodic reporting.
Yes. AI is used as decision support to flag gaps, contradictions, or weak justification, and to explain what needs attention and why. It can suggest draft text based strictly on user-provided information, but outputs remain under human control.
Regi is built around a strict human-in-the-loop model with clear review/sign-off points, version control, and audit trails linking inputs, assumptions, and outputs. AI suggestions are labelled and do not replace professional judgement or make regulatory decisions autonomously.
Regi includes Document Wizards: step-by-step guided flows for creating PMS plans, clinical evaluation reports, risk management files, and other core regulatory artefacts. Each step is accompanied by a Guidance Panel that explains in plain language what is required, why it matters under the applicable framework, and what a strong response looks like — so you are building the document correctly as you go, not correcting it afterwards.

Get started

Get started with Regi today

Whether you're a startup entering regulated markets for the first time or a multi-product team looking for operational consistency, Regi is built for you.

Try Regi free Contact us about Enterprise
0
Skip to Content
Regi - Intelligent compliance.
Regi - Intelligent compliance.
Meet Regi
Start ups and early stage
Multi-Product Teams
Consulting and Advisory
Get in touch
Regi - Intelligent compliance.
Regi - Intelligent compliance.
Meet Regi
Start ups and early stage
Multi-Product Teams
Consulting and Advisory
Get in touch
Meet Regi
Start ups and early stage
Multi-Product Teams
Consulting and Advisory
Get in touch

Contact ‍Sustainability‍ ‍Privacy‍ ‍Cookies‍ ‍Terms of use‍ ‍Accessibility

© 2026. Regi Digital Ltd.
Registered in England & Wales.
Company Number 16914302